Communiqué de presse

Research and Development (R&D) in the Business Enterprise Sector in 2021 In 2021, enterprises invested almost 17 billion in research in Switzerland

19.12.2022 - In 2021, private enterprises in Switzerland spent CHF 16.8 billion on their in-house research and development activities (R&D). This represented an increase of +4% per year since 2019, the year of the last survey. With a total of CHF 6.2 billion, the pharmaceutical sector invested the most in R&D in Switzerland. Almost 62 000 people were involved in R&D activities. A quarter of the workforce was made up of women. These are the main results of a study carried out by the Federal Statistical Office (FSO) in partnership with economiesuisse.

You can find further information such as tables and graphs in the press releases in German, French and Italian. The English version only contains the lead of the press release.